Global Hemodialysis and Peritoneal Dialysis Market to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
54
Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024

NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- The global hemodialysis and peritoneal dialysis market is expected to grow from USD 67.2 billion in 2017 to USD 99.7 billion in 2024, at a CAGR of 5.9% from 2018 to 2024. The growth in the market is attributed to the increasing number of patients diagnosed with end-stage renal disease along with growing number of patients suffering from diabetes and high blood pressure. Moreover, shortage of kidney donors, favorable healthcare insurance policies, and technological advancements and novel product innovations across the globe are also propelling the market growth.

Key findings from the report:

  • On the basis of type,
    • The hemodialysis segment held the major share of the market in 2017. The growth is attributed to the increasing incidences of chronic renal dysfunction and rising number of kidney failure cases. Moreover, increasing number of patients affected with end-stage renal diseases which require hemodialysis, and growing number of hemodialysis centers across the globe are also driving the growth.
    • The peritoneal dialysis segment is expected to witness lucrative growth during the forecast period owing to growing number of patients affected with hypertension and diabetes which may cause kidney failures and require peritoneal dialysis. Moreover, technological advancements and growing investments in research and development activities are further propelling the market growth.
  • On the basis of end-use, the dialysis centers & hospital-based dialysis segment held the major share of the market in 2017. This is mainly attributed to large number of dialysis performed in hospitals, and growing number of dialysis centers worldwide.
  • Geographically, North America held the major share of the global market in 2017. Europe held the second largest share of the market in 2017. Asia-Pacific is expected to witness the highest CAGR during the forecast period.
  • Some of the key companies operating in the market include Fresenius Medical Care AG & Co. KGaA, Integer Holdings Corporation, Nxstage Medical, Inc., Allmed Medical Care Holdings Limited, Davita Healthcare Partners Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Diaverum Deutschland GmbH, Baxter International Inc., B. Braun Melsungen AG, and Nikkiso Co., Ltd., among others

Rising number of end-stage renal and chronic kidney diseases resulting in strong demand for Hemodialysis and Peritoneal Dialysis

The requirement of hemodialysis and peritoneal dialysis occurs when a patient's kidneys can no longer remove extra and waste fluids adequately from the body. Hemodialysis and peritoneal dialysis are the treatments option to clean the blood and extra fluids. In these procedures, blood passes through artificial kidneys with the help of dialyzer and dialysis machine. High blood pressure and diabetes are the most common causes of the kidney diseases along with obesity. Approximately 10% of the population across the globe is affected by chronic kidney diseases and a large number of patients die each year due to lack of affordable treatments and shortage of kidney donors. The increasing number of patients diagnosed with end-stage renal or chronic kidney diseases has led to the strong demand for hemodialysis and peritoneal dialysis. Moreover, among the patients diagnosed with end-stage renal diseases, approximately 90% of the patients require hemodialysis and about 10% of the patients adopt peritoneal dialysis. Hemodialysis and peritoneal dialysis treatment is the most widely accepted treatment method worldwide.

Browse full research report with TOC on “ Global Hemodialysis and Peritoneal Dialysis Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024 ” at: https://www.energiasmarketresearch.com/global...et-report/   

To purchase report:  sales@energiasmarketresearch.com

Hemodialysis and Peritoneal Dialysis Market – Regional insight

Geographically, North America held the largest share of the market in 2017. The growth in the region is mainly attributed to the high prevalence of diabetes and hypertension patients coupled with the adoption of new technologies. Moreover, growing number of dialysis centers and increasing awareness regarding the availability of various treatment options are further boosting the market growth in the region. Europe held the second largest share of the market in 2017. The growth in the region is attributed to the higher incidence of chronic kidney diseases, new product innovations, and growing number of patients suffering from diabetes and hypertension. Moreover, rising prevalence of end-stage renal diseases and growing aging population is further propelling the market growth in the region. Asia-Pacific held the third largest share of the market and is expected to witness the highest CAGR during the forecast period due to increasing awareness regarding kidney diseases, shortage of kidney donors and growing investments in research and development activities in the region.

This report segments global hemodialysis and peritoneal dialysis market based on type, product, end-use, and region.

By Type

  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

By Product

  • Device
    • Machine
      • Center-Use Hemodialysis Machines
      • Home-Use Hemodialysis Machines
    • Dialyzer
      • Flux Type
        • High-Flux Dialyzers
        • Low-Flux Dialyzers
      • Material Type
        • Synthetic Dialyzers
        • Cellulose-Based Dialyzers
    • Water Treatment System
      • Central Water Disinfection Systems
      • Portable Water Disinfection Systems
    • Others
  • Consumables
    • Bloodline
    • Concentrates
      • Acidic
      • Alkaline
    • Catheters
    • Others
  • Services

By End-use

  • Home-based Dialysis
  • Dialysis centers & hospital-based dialysis

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa (MEA)

About Energias Market Research Pvt. Ltd. -

Energias Market Research launched with the objective to provide in-depth market analysis, business research solutions, and consultation that is tailored to our client’s specific needs based on our impeccable research methodology.

With a wide range of expertise from various industrial sectors and more than 50 industries that include  energy, chemical and materials, information communication technology, semiconductor industries, healthcare and daily consumer goods , etc. We strive to provide our clients with a one-stop solution for all research and consulting needs.

Our comprehensive industry-specific knowledge enables us in creating high quality global research outputs. This wide-range capability differentiates us from our competitors.

Contact:

Mr. Alan Andrews

Business Development Manager

For any queries email us: info@energiasmarketresearch.com

To purchase report: sales@energiasmarketresearch.com

Call us: +1-716-239-4915

Visit: https://www.energiasmarketresearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 3

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 3

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 3

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 5

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 1

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 2

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 3

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading

Top 5 Most Recently Viewed Articles

Natural Diamonds Resilient Amid Market Shifts and Trends

Updated Category News Views 679

The Strength of Natural Diamonds in Today's Market As we enter a new year, the natural diamond market has shown a robust performance, providing encouraging signs of stability, strength, and growth. Jewelers have reported solid year-end results, showcasing steady or improved sales levels compared to previous periods. This positive trend reinforces the perception of natural...

Continue Reading
Bicara Therapeutics' Plans for Public Offering Showcase Growth

Updated Category News Views 183

Overview of Bicara Therapeutics' Initial Public Offering Bicara Therapeutics Inc. (NASDAQ: BCAX), an innovative biopharmaceutical company currently in the clinical stage, has just taken an exciting step forward. They've announced the pricing for their initial public offering (IPO), which includes 17,500,000 shares of common stock, each priced at a competitive $18.00. This...

Continue Reading
Class Action Alert for Semtech Corporation Investors

Updated Category News Views 107

Legal Update for Semtech Corporation Shareholders The Gross Law Firm has released an important notice specifically for shareholders of Semtech Corporation (NASDAQ: SMTC). This notice comes in light of a class action lawsuit that has been filed, and it outlines essential details regarding the lawsuit and actions that shareholders can take to safeguard their rights....

Continue Reading
Critical Insights on the Beyond Meat Securities Investigation

Updated Category News Views 241

Understanding the Investigation into Beyond Meat Beyond Meat, Inc. (NASDAQ: BYND), renowned for its innovative plant-based meat alternatives, is currently under scrutiny regarding potential violations of federal securities laws. This investigation, announced by a leading securities law firm, raises concerns for investors who may have suffered losses due to possible...

Continue Reading
Immunic Navigates Investor Events As Trials Advance

Updated Category News Views 2

Braving the Investor Circuit Immunic's ready to make some moves this July—this crew's diving headfirst into a trio of investor conferences. They're not just chitchatting; they’re taking one-on-one meetings, holding fireside chats. What’s the big draw? Their brainchild, vidofludimus calcium (IMU-838), which is knee-deep in phase 3 trials for relapsing multiple...

Continue Reading